國立虎尾科技大學 |

Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders/ edited by Janusz K. Rybakowski, Alessandro Serretti.
其他作者:	Rybakowski, Janusz K.
面頁冊數:	IX, 117 p.online resource. :
Contained By:	Springer Nature eBook
標題:	Psychopharmacology. -
電子資源:	https://doi.org/10.1007/978-3-319-27040-1
ISBN:	9783319270401

Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders
Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders[electronic resource] /edited by Janusz K. Rybakowski, Alessandro Serretti. - 1st ed. 2016. - IX, 117 p.online resource.

1. Pharmacogenetics of the Efficacy of Antipsychotic Drugs in Schizophrenia -- 2. Pharmacogenetics of Serious Antipsychotic Side-Effects -- 3. Pharmacogenetics of the Efficacy and Side Effects of Antidepressant Drugs -- 4. Genomic Studies of Treatment Resistance in Major Depressive Disorders -- 5. Complementation of Pharmacogenetics with Biomarkers and Neuroimaging in Major Depression -- 6. Pharmacogenetics of Mood Stabilizers -- 7. Practical Application of Pharmacogenetics of Antipsychotic, Antidepressant and Mood-Stabilizing Drugs.

Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed. Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice.

ISBN: 9783319270401

Standard No.: 10.1007/978-3-319-27040-1doiSubjects--Topical Terms:

644799
Psychopharmacology.

LC Class. No.: RM315-334

Dewey Class. No.: 615.78

Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders
LDR:02796nam a22003975i 4500 001 977562
003 DE-He213
005 20200702092807.0
007 cr nn 008mamaa
008 201211s2016 gw | s |||| 0|eng d
020 $a 9783319270401 $9 978-3-319-27040-1
024 7 $a 10.1007/978-3-319-27040-1 $2 doi
035 $a 978-3-319-27040-1
050 4 $a RM315-334
072 7 $a MMGW $2 bicssc
072 7 $a MED105020 $2 bisacsh
072 7 $a MKGW $2 thema
082 0 4 $a 615.78 $2 23
245 1 0 $a Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders $h [electronic resource] / $c edited by Janusz K. Rybakowski, Alessandro Serretti.
250 $a 1st ed. 2016.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Adis, $c 2016.
300 $a IX, 117 p. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a 1. Pharmacogenetics of the Efficacy of Antipsychotic Drugs in Schizophrenia -- 2. Pharmacogenetics of Serious Antipsychotic Side-Effects -- 3. Pharmacogenetics of the Efficacy and Side Effects of Antidepressant Drugs -- 4. Genomic Studies of Treatment Resistance in Major Depressive Disorders -- 5. Complementation of Pharmacogenetics with Biomarkers and Neuroimaging in Major Depression -- 6. Pharmacogenetics of Mood Stabilizers -- 7. Practical Application of Pharmacogenetics of Antipsychotic, Antidepressant and Mood-Stabilizing Drugs.
520 $a Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed. Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice.
650 0 $a Psychopharmacology. $3 644799
650 0 $a Human genetics. $3 596505
650 2 4 $a Human Genetics. $3 593893
700 1 $a Rybakowski, Janusz K. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1106221
700 1 $a Serretti, Alessandro. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1106222
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319270388
776 0 8 $i Printed edition: $z 9783319270395
776 0 8 $i Printed edition: $z 9783319800615
856 4 0 $u https://doi.org/10.1007/978-3-319-27040-1
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)